Početna stranicaPRGO • NYSE
add
Perrigo Company PLC
Preth. zaklj. cijena
24,38 $
Dnevni raspon
24,13 $ - 24,35 $
Godišnji raspon
23,89 $ - 33,96 $
Tržišna kapitalizacija
3,29 mlr. USD
Prosječna količina
1,30 mil.
P/E omjer
-
Prinos dividende
4,57 %
Glavno tržište vrijednosnica
NYSE
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
(USD) | ruj 2024.info | Godišnja promjena |
---|---|---|
Prihod | 1,09 mlr. | −3,23 % |
Operativni troškovi | 290,90 mil. | −12,72 % |
Neto dohodak | −21,00 mil. | −247,89 % |
Neto profitabilnost | −1,93 | −253,17 % |
Zarada po dionici | 0,81 | 26,56 % |
EBITDA | 195,80 mil. | 15,93 % |
Efektivna porezna stopa | 180,73 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
(USD) | ruj 2024.info | Godišnja promjena |
---|---|---|
Gotovinska i kratkoročna ulaganja | 1,46 mlr. | 144,39 % |
Ukupna imovina | 11,20 mlr. | 4,14 % |
Ukupne obveze | 6,64 mlr. | 10,25 % |
Ukupni kapital | 4,57 mlr. | — |
Dionice u optjecaju | 136,43 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 0,73 | — |
Povrat imovine | 2,63 % | — |
Povrat kapitala | 3,09 % | — |
Tok novca
Neto promjena novca
(USD) | ruj 2024.info | Godišnja promjena |
---|---|---|
Neto dohodak | −21,00 mil. | −247,89 % |
Gotovina od poslovanja | 42,20 mil. | −66,10 % |
Gotovina iz ulaganja | 212,70 mil. | 792,83 % |
Gotovina iz financiranja | 653,30 mil. | 1.608,78 % |
Neto promjena novca | 920,70 mil. | 2.036,19 % |
Slobodan tok novca | 219,62 mil. | 174,19 % |
Više
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.
Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value. Wikipedia
Glavni izvršni direktor
Osnovano
1887
Web-lokacija
Zaposlenici
9.140